|
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified |
Sep. 30, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Current assets | ||
| Cash and cash equivalents, $89 reserved at September 30, 2014 | $ 3,111 | $ 6,258 |
| Other current assets | 277 | 233 |
| Total current assets | 3,388 | 6,491 |
| Patent license rights, net | 705 | 823 |
| Furniture and equipment, net | 0 | 3 |
| Total assets | 4,093 | 7,317 |
| Current liabilities | ||
| Accounts payable | 225 | 88 |
| Other accrued liabilities | 246 | 12 |
| Total current liabilities | 471 | 100 |
| Capstone Therapeutics Corp. Stockholders' Equity | ||
| Common Stock $.0005 par value; 100,000,000 shares authorized;40,885,411 shares in 2014 and 2013 issued and outstanding | 20 | 20 |
| Additional paid-in capital | 189,267 | 189,215 |
| Accumulated deficit | (185,665) | (182,018) |
| Total Capstone Therapeutics Corp. stockholders' equity | 3,622 | 7,217 |
| Noncontrolling interest | 0 | 0 |
| Total equity | 3,622 | 7,217 |
| Total liabilities and equity | $ 4,093 | $ 7,317 |